Esperion Therapeutics Inc CLEAR Outcomes Company Update: Detailed Results Discussion Call Transcript
Good day, and thank you for standing by. Welcome to the Clear Outcomes Data Shareholder Analyst Call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Tiffany Aldrich, Associate Director, Corporate Communications. Please go ahead.
Good morning, and welcome to Esperion's company update conference call. I'm Tiffany Aldrich, and I'm part of the Corporate Communications team here at Esperion.
I want to remind callers that the information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in our March 4 press release and SEC
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |